Dr. Thomas A. Medsger Jr. Joins iBio Clinical Advisory Board
September 02, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Sep 2, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of biotechnology for developing and manufacturing plant-made pharmaceutical products, has appointed Thomas...
iBio Receives European Patent Allowances for Protein Expression Technology
August 28, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Aug 28, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, received notices of intention to...
iBio Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital
August 26, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Aug 26, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, today announced it has...
iBio Forms Marketing Collaboration With Kanematsu Chemicals Corporation to Target Japanese Market
August 14, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Aug 14, 2014) - iBio, Inc. (NYSE MKT: IBIO), and Kanematsu Chemicals Corporation, part of Kanematsu Corporation (TSE: 8020), have entered into a collaboration agreement...
iBio Appoints Another IPF Expert, Dr. J. Terrill Huggins, to Clinical Advisory Board
July 30, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jul 30, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed J....
iBio Appoints Dr. Richard M. Silver to Clinical Advisory Board
July 21, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jul 21, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed Richard...
iBio Appoints Dr. Timothy Blackwell to New Clinical Advisory Board
July 16, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jul 16, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed Timothy...
iBio Expands Commercial Collaboration With Bio-Manguinhos and Fraunhofer
June 17, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jun 17, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, amended its...
iBio Expands IP Protection of Biotherapeutic Product for Treatment of Fibrosis
June 10, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jun 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the issue by...
iBio European Patent on iBioModulator Technology Emerges From Opposition Period
June 05, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jun 5, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, has surpassed the opposition...